Literature DB >> 26132089

A Complex Presentation of Pediatric Neuroleptic Malignant Syndrome Related to Polypharmacy in a 12-Year-Old Male.

Nathaniel Sharon1, Chandra Cullen1, Kara Martinez1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26132089      PMCID: PMC5076478          DOI: 10.1089/cap.2014.0125

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


× No keyword cloud information.
  17 in total

1.  [A non-phenothiazine and non-reserpine major neuroleptic, haloperidol, in the treatment of psychoses].

Authors:  J DELAY; P PICHOT; T LEMPERIERE; B ELISSALDE; F PEIGNE
Journal:  Ann Med Psychol (Paris)       Date:  1960-01       Impact factor: 0.380

2.  Are neuroleptic malignant syndrome and serotonin syndrome the same syndrome?

Authors:  Debbie Steele; Norman L Keltner; Teena M McGuiness
Journal:  Perspect Psychiatr Care       Date:  2010-12-14       Impact factor: 2.186

3.  Neuroleptic malignant syndrome associated with bromocriptine withdrawal in Parkinson's disease--a case report.

Authors:  Yung-Fu Wu; Yuk-Shing Kan; Chen-Hong Yang
Journal:  Gen Hosp Psychiatry       Date:  2011-01-08       Impact factor: 3.238

4.  Case report of neuroleptic malignant syndrome associated with withdrawal from amantadine.

Authors:  D M Simpson; G C Davis
Journal:  Am J Psychiatry       Date:  1984-06       Impact factor: 18.112

Review 5.  Neuroleptic malignant syndrome.

Authors:  J L Levenson
Journal:  Am J Psychiatry       Date:  1985-10       Impact factor: 18.112

6.  Neuroleptic withdrawal versus serotonergic syndrome in an 8-year-old child.

Authors:  Elsa M M Godinho; Anne E Thompson; David J Bramble
Journal:  J Child Adolesc Psychopharmacol       Date:  2002       Impact factor: 2.576

Review 7.  Extrapyramidal reactions and the selective serotonin-reuptake inhibitors.

Authors:  C F Caley
Journal:  Ann Pharmacother       Date:  1997-12       Impact factor: 3.154

8.  Neurotoxic syndrome associated with risperidone and fluvoxamine.

Authors:  Roy R Reeves; James E Mack; John J Beddingfield
Journal:  Ann Pharmacother       Date:  2002-03       Impact factor: 3.154

9.  A neuroleptic malignantlike syndrome due to levodopa therapy withdrawal.

Authors:  J H Friedman; S S Feinberg; R G Feldman
Journal:  JAMA       Date:  1985-11-15       Impact factor: 56.272

Review 10.  Neuroleptic malignant syndrome in children and adolescents.

Authors:  R R Silva; D M Munoz; M Alpert; I R Perlmutter; J Diaz
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1999-02       Impact factor: 8.829

View more
  1 in total

Review 1.  Neuroleptic malignant syndrome: an easily overlooked neurologic emergency.

Authors:  Ramadhan Oruch; Ian F Pryme; Bernt A Engelsen; Anders Lund
Journal:  Neuropsychiatr Dis Treat       Date:  2017-01-16       Impact factor: 2.570

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.